Jeff E. Knight - Dec 31, 2022 Form 5 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
Chief Operating Officer
Signature
/s/ Marc Wilson
Stock symbol
CRNX
Transactions as of
Dec 31, 2022
Transactions value $
$8,141
Form type
5
Date filed
1/27/2023, 03:27 PM
Previous filing
Jul 29, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Other $8.14K +537 +10.85% $15.16 5.49K Nov 20, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),